Sirtris Pharmaceuticals , Nasdaq: SIRT
A biopharmaceutical company developing drugs to treat age-related diseases.
Industry: Health Care
First Day Return: +7.6%
Industry: Health Care
SIRT
A biopharmaceutical company developing drugs to treat age-related diseases.
| IPO Data | |
|---|---|
| IPO File Date | 03/01/2007 |
| Offer Price | $10.00 |
| Price Range $9.00 - $11.00 | |
| Offer Shares (mm) | 6.0 |
| Deal Size ($mm) | $60 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 05/22/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $60 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Cambridge, MA, United States |
| Founded | 2004 |
| Employees at IPO | 57 |
| Website www. sirtrispharma.com | |
IPO News for Sirtris Pharmaceuticals
Sirtris Pharmaceuticals (SIRT) Performance
